In patients with triple-negative breast cancer, ctDNA was most commonly identified within six months after treatment, reflecting the disease’s typical pattern of early recurrence.
Despite being declared cancer-free after initial treatment, I grapple with survivor’s guilt, questioning why my lymphoma responded to therapy while others did not.
An NDA has been accepted by the FDA for the combination of avutometinib and defactinib in KRAS-mutated recurrent low-grade serous ovarian cancer.
Click on the article title to read more.
An expert explained recent findings from a study of pregnant women with breast cancer who underwent chemotherapy and fared better than nonpregnant patients.
The Nursing and Midwifery Council (NMC) has appointed a new adviser to help improve its fitness to practise (FtP) processes.
The FDA approved several drugs in December for the treatment of diseases, including pancreatic adenocarcinoma, lung cancer, skin cancer and graft-versus-host disease.
The RCN chief has renewed her commitment to improving pay for all nursing staff across the UK in a New Year message to the profession.
Read about new analysis by the Royal College of Nursing which shows the impact of a fall in foreign aid spending by the UK Government.
One research noted the persistent efforts to develop new treatments for myeloproliferative neoplasms (MPNs), a commitment that remains strong despite some setbacks.
As a nurse practitioner (NP), you know first-hand about your patients’ needs and the challenges many people face when they encounter barriers to health care…
